Blood concentrations of new designer benzodiazepines in forensic cases - PubMed (original) (raw)
Blood concentrations of new designer benzodiazepines in forensic cases
Gudrun Høiseth et al. Forensic Sci Int. 2016 Nov.
Abstract
Introduction: A number of new designer benzodiazepines have reached the illegal drug market over the past years. Toxicological interpretation of concentrations of these drugs in blood is quite challenging as very limited human data have previously been published. The aim of this study was to report blood concentrations of new designer benzodiazepines in a population of drugged drivers as well as some other criminal offenders, and to relate this to clinical impairment.
Methods: The present material represents cases involving new designer benzodiazepines (clonazolam, diclazepam, flubromazepam, flubromazolam and pyrazolam) and etizolam, submitted for analyses during the period July 1, 2013-May 31, 2016. Analyses were performed using an ultra-performance liquid chromatography-tandem mass spectrometry method. Blood concentrations and results from the clinical test of impairment are reported.
Results: New designer benzodiazepines were detected in 77 cases during the study period. The median (range) concentrations were 0.012mg/L (0.00048-0.10) for flubromazolam (n=25), 0.055mg/L (0.0047-1.2) for flubromazepam (n=24), 0.013mg/L (0.0021-0.057) for diclazepam (n=15), 0.050mg/L (0.019-0.17) for etizolam (n=14), 0.0053mg/L (0.0019-0.011) for clonazolam (n=7) and 0.074mg/L for pyrazolam (n=1). In six cases, designer benzodiazepines were the only drugs detected in blood, and in two of those cases, the physician had given the conclusion of "considerably impaired" upon performing the clinical test for impairment.
Conclusion: Given the lack of previously published data on human concentrations, results presented in this study could be helpful in interpretation of blood concentrations of new designer benzodiazepines. This is crucial for the assessment of the importance of toxicological results in suspected drugged drivers, rape victims, etc.
Keywords: Designer benzodiazepines; Driving under the influence of drugs; Forensic toxicology; New psychoactive substances.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Brunetti P, et al. Pharmaceuticals (Basel). 2021 Jun 11;14(6):560. doi: 10.3390/ph14060560. Pharmaceuticals (Basel). 2021. PMID: 34208284 Free PMC article. Review. - Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
Heide G, Høiseth G, Middelkoop G, Øiestad ÅML. Heide G, et al. J Anal Toxicol. 2020 Dec 12;44(8):905-914. doi: 10.1093/jat/bkaa043. J Anal Toxicol. 2020. PMID: 32369173 Free PMC article. - Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M, Helander A, Hansson T, Beck O. Pettersson Bergstrand M, et al. Drug Test Anal. 2017 Apr;9(4):640-645. doi: 10.1002/dta.2003. Epub 2016 Jul 1. Drug Test Anal. 2017. PMID: 27366870 - In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M, Richter LHJ, Maurer HH, Wagmann L, Meyer MR. Pettersson Bergstrand M, et al. Drug Test Anal. 2019 Jan;11(1):45-50. doi: 10.1002/dta.2463. Epub 2018 Aug 9. Drug Test Anal. 2019. PMID: 29996009 - Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
Wu D, Fu L. Wu D, et al. Arh Hig Rada Toksikol. 2023 Dec 29;74(4):224-231. doi: 10.2478/aiht-2023-74-3771. eCollection 2022. Arh Hig Rada Toksikol. 2023. PMID: 38146763 Free PMC article. Review.
Cited by
- Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review.
Kaye AD, Tassin JP, Upshaw WC, Robichaux CM, Frolov MV, Dupaquier MM, Fox JE, Sterritt J, Mathew J, Shekoohi S, Kaye AM, Edinoff AN. Kaye AD, et al. Neurol Ther. 2024 Aug;13(4):965-973. doi: 10.1007/s40120-024-00628-3. Epub 2024 May 10. Neurol Ther. 2024. PMID: 38727766 Free PMC article. Review. - Development and validation of a liquid chromatography tandem mass spectrometry method for the analysis of 53 benzodiazepines in illicit drug samples.
Whitehead HD, Hayes KL, Swartz JA, Lieberman M. Whitehead HD, et al. Forensic Chem. 2023 Sep;35:100512. doi: 10.1016/j.forc.2023.100512. Epub 2023 Jun 16. Forensic Chem. 2023. PMID: 37483533 Free PMC article. - Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019-2020).
Watts C, Martin TL. Watts C, et al. J Anal Toxicol. 2022 Aug 13;46(7):719-725. doi: 10.1093/jat/bkab106. J Anal Toxicol. 2022. PMID: 34570874 Free PMC article. - Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Brunetti P, et al. Pharmaceuticals (Basel). 2021 Jun 11;14(6):560. doi: 10.3390/ph14060560. Pharmaceuticals (Basel). 2021. PMID: 34208284 Free PMC article. Review. - Benzodiazepines reported in NFLIS-Drug, 2015 to 2018.
Bollinger K, Weimer B, Heller D, Bynum N, Grabenauer M, Pressley D, Smiley-McDonald H. Bollinger K, et al. Forensic Sci Int Synerg. 2021 Feb 9;3:100138. doi: 10.1016/j.fsisyn.2021.100138. eCollection 2021. Forensic Sci Int Synerg. 2021. PMID: 33665593 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous